Related Experiment Video

Updated: Aug 9, 2026

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
12:03

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors

Published on: June 7, 2016

Signaling crosstalk angiotensin II receptor subtypes and insulin

Masatsugu Horiuchi1, Masaki Mogi, Masaru Iwai

  • 1Department of Molecular and Cellular Biology, Division of Medical Biochemistry and Cardiovascular Biology, Ehime University School of Medicine, Japan.

Endocrine Journal
|March 18, 2006
PubMed

Insights

Angiotensin II receptor blockers (ARBs) show vasoprotective effects, potentially improving insulin sensitivity and reducing diabetes risk in hypertensive patients. Further research into their signaling pathways could prevent cardiovascular events.

Area of Science:

  • Endocrinology
  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Insulin resistance is linked to hypertension and increased cardiovascular risk.
  • Angiotensin II receptor blockers (ARBs) demonstrate vasoprotective effects and may reduce new-onset diabetes.
  • Obesity, a hypertension risk factor, involves Angiotensin II receptor subtypes in insulin resistance.

Purpose of the Study:

  • To explore the relationship between Angiotensin II receptor subtypes and insulin sensitivity.
  • To understand the crosstalk between Angiotensin II and insulin signaling in various tissues.
  • To elucidate the clinical relevance of ARBs in managing insulin resistance and preventing cardiovascular events.

Main Methods:

  • Review of existing data on Angiotensin II receptor subtype activation.
  • Analysis of insulin signaling pathways in diabetic animal models.
  • Investigation of vascular remodeling in conjunction with insulin signaling.

Main Results:

  • Activation of Ang II receptor subtypes influences insulin sensitivity at multiple signaling sites.
  • Ang II receptor subtypes play a role in insulin resistance associated with obesity.
  • ARBs may offer vasoprotective benefits and impact insulin resistance.

Conclusions:

  • Understanding the crosstalk between Ang II and insulin signaling is crucial for managing insulin resistance.
  • ARBs hold potential for preventing cardiovascular complications in insulin-resistant individuals.
  • Targeting Ang II receptor subtypes may offer therapeutic benefits for metabolic and cardiovascular health.

More Related Videos

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain08:32

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain

Published on: January 4, 2018

Precise Visualization of Insulin Receptors A and B in Murine Brain with an RNA In Situ Hybridization Assay08:34

Precise Visualization of Insulin Receptors A and B in Murine Brain with an RNA In Situ Hybridization Assay

Published on: July 15, 2025

Related Concept Videos

Endocrine Signaling01:45

Endocrine Signaling

Endocrine cells produce hormones to communicate with remote target cells found in other organs. The hormone reaches these distant areas using the circulatory system. This exposes the whole organism to the hormone but only those cells expressing hormone receptors or target cells are affected. Thus, endocrine signaling induces slow responses from its target cells but these effects also last longer.
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Adrenergic Receptors: ɑ Subtype01:31

Adrenergic Receptors: ɑ Subtype

Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...